These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11467412)

  • 21. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin.
    Elsner M; Guldbakke B; Tiedge M; Munday R; Lenzen S
    Diabetologia; 2000 Dec; 43(12):1528-33. PubMed ID: 11151762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal B-cell function in neonatally streptozotocin-diabetic rats: insensitivity to alloxan toxicity.
    Grill V; Westberg M
    Endocrinology; 1987 Dec; 121(6):2171-6. PubMed ID: 2445559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotoxicological effects of streptozotocin and alloxan: in vitro and in vivo studies.
    Diab RA; Fares M; Abedi-Valugerdi M; Kumagai-Braesch M; Holgersson J; Hassan M
    Immunol Lett; 2015 Feb; 163(2):193-8. PubMed ID: 25573197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells.
    Fernandez-Mejia C; Davidson MB
    Pancreas; 1993 Sep; 8(5):589-96. PubMed ID: 8302795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Islet cell metabolism is reflected by the MTT (tetrazolium) colorimetric assay.
    Janjic D; Wollheim CB
    Diabetologia; 1992 May; 35(5):482-5. PubMed ID: 1387858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
    Blumentrath J; Neye H; Verspohl EJ
    Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozocin toxicity.
    LeDoux SP; Hall CR; Forbes PM; Patton NJ; Wilson GL
    Diabetes; 1988 Aug; 37(8):1015-9. PubMed ID: 2968936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors.
    Yamagami T; Miwa A; Takasawa S; Yamamoto H; Okamoto H
    Cancer Res; 1985 Apr; 45(4):1845-9. PubMed ID: 2983889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of streptozotocin on a clonal isolate of rat insulinoma cells.
    Ledoux SP; Wilson GL
    Biochim Biophys Acta; 1984 Aug; 804(4):387-92. PubMed ID: 6087920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of HaCat keratinocytes to diabetogenic toxins.
    Harel A; Bloch O; Vardi P; Bloch K
    Biochem Pharmacol; 2002 Jan; 63(2):171-8. PubMed ID: 11841791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-O-methyl-D-glucose transport in tumoral insulin-producing cells.
    Malaisse WJ; Giroix MH; Malaisse-Lagae F; Sener A
    Am J Physiol; 1986 Dec; 251(6 Pt 1):C841-6. PubMed ID: 3024495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linderane protects pancreatic β cells from streptozotocin (STZ)-induced oxidative damage.
    Zhang H; Zhu C; Sun Z; Yan X; Wang H; Xu H; Ma J; Zhang Y
    Life Sci; 2019 Sep; 233():116732. PubMed ID: 31394125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulinoma cells in culture show pronounced sensitivity to alloxan-induced oxidative stress.
    Zhang H; Ollinger K; Brunk U
    Diabetologia; 1995 Jun; 38(6):635-41. PubMed ID: 7672482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells.
    de-Mello MA; Flodström M; Eizirik DL
    Biochem Pharmacol; 1996 Dec; 52(11):1703-9. PubMed ID: 8986132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective role of superoxide dismutase against diabetogenic drugs.
    Gandy SE; Buse MG; Crouch RK
    J Clin Invest; 1982 Sep; 70(3):650-8. PubMed ID: 6213639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of insulin secretion from novel engineered insulinoma cell lines.
    Hohmeier HE; BeltrandelRio H; Clark SA; Henkel-Rieger R; Normington K; Newgard CB
    Diabetes; 1997 Jun; 46(6):968-77. PubMed ID: 9166667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats.
    Hardin DS; Dominguez JH; Garvey WT
    Metabolism; 1993 Oct; 42(10):1310-5. PubMed ID: 8412743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanisms of alloxan- and streptozotocin-induced diabetes.
    Lenzen S
    Diabetologia; 2008 Feb; 51(2):216-26. PubMed ID: 18087688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic mice expressing Shb adaptor protein under the control of rat insulin promoter exhibit altered viability of pancreatic islet cells.
    Welsh M; Christmansson L; Karlsson T; Sandler S; Welsh N
    Mol Med; 1999 Mar; 5(3):169-80. PubMed ID: 10404514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of retinyl palmitate on streptozotocin- and alloxan-induced beta cell toxicity and diabetes in the rat.
    Chertow BS; Webb MD; Leidy JW; Cordle MB
    Res Commun Chem Pathol Pharmacol; 1989 Jan; 63(1):27-44. PubMed ID: 2521747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.